Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lithium pharmacokinetics.

P J Goodnick1, C B Schorr-Cain

  • 1Department of Psychiatry, University of Miami, FL 33136.

Psychopharmacology Bulletin
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Lithium treatment for bipolar disorder has advanced significantly, with new insights into renal function, drug monitoring, and interactions. This review covers current knowledge and future directions for lithium therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Depression in the new millennium.

CNS spectrums·2008
Same author

Psychopharmacology of depression in the next millennium.

CNS spectrums·2008
Same author

Antipsychotic medication: effects on regulation of glucose and lipids.

Expert opinion on pharmacotherapy·2002
Same author

Ziprasidone: profile on safety.

Expert opinion on pharmacotherapy·2002
Same author

Rapid cycling bipolar disorder.

Expert opinion on pharmacotherapy·2002
Same author

Vagus nerve stimulation in depression.

Expert opinion on pharmacotherapy·2001
Same journal

Catatonia Associated with Psychosis: A Retrospective Study of 164 Inpatients.

Psychopharmacology bulletin·2026
Same journal

Escitalopram-Induced Spasmodic Torticollis in an Early Psychosis Service: A Case Report.

Psychopharmacology bulletin·2026
Same journal

Beyond Exposure: Standardizing Buprenorphine Training in Pain Medicine Fellowship.

Psychopharmacology bulletin·2026
Same journal

Association of CBC-Derived Indices of Inflammation with Response to Glecaprevir/Pibrentasvir for PTSD.

Psychopharmacology bulletin·2026
Same journal

When Care Becomes Dangerous: Patient Assaults Against Physicians.

Psychopharmacology bulletin·2026
Same journal

Efficacy and Safety of Centanafadine in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Psychopharmacology bulletin·2026
See all related articles

Area of Science:

  • Pharmacology
  • Nephrology
  • Psychiatry

Background:

  • Lithium has been a cornerstone in treating bipolar affective disorder since the 1960s.
  • Extensive research has elucidated lithium's impact on renal function and its pharmacokinetics.
  • Understanding lithium's interactions with other medications is crucial for patient safety.

Purpose of the Study:

  • To review current knowledge on lithium's effects on renal function.
  • To discuss advancements in lithium administration and monitoring.
  • To highlight significant drug interactions involving lithium.

Main Methods:

  • Literature review of studies on lithium therapy.
  • Analysis of research on lithium's renal and kinetic effects.
  • Examination of clinical data on drug interactions.

Related Experiment Videos

Main Results:

  • Significant progress has been made in understanding lithium's renal effects and kinetics.
  • Improved methods for serum lithium level monitoring are available.
  • Key interactions with diuretics and NSAIDs require careful management.

Conclusions:

  • Continued research is vital for optimizing lithium therapy in bipolar disorder.
  • Awareness of renal function and drug interactions is essential for safe and effective lithium use.
  • Future developments will focus on refining lithium's therapeutic application and safety profile.